We are live on ! Find out more
TTOO

T2 Biosystems, Inc

Delisted

TTOO was delisted on the 11th of February, 2025.

89 hedge funds and large institutions have $203M invested in T2 Biosystems, Inc in 2018 Q2 according to their latest regulatory filings, with 52 funds opening new positions, 17 increasing their positions, 10 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

550% more first-time investments, than exits

New positions opened: 52 | Existing positions closed: 8

98% more funds holding

Funds holding: 4589 (+44)

70% more repeat investments, than reductions

Existing positions increased: 17 | Existing positions reduced: 10

65% more capital invested

Capital invested by funds: $123M → $203M (+$80.3M)

61% more call options, than puts

Call options by funds: $2.36M | Put options by funds: $1.47M

50% less funds holding in top 10

Funds holding in top 10: 21 (-1)

Holders
89
Holders Change
+44
Holders Change %
+97.78%
% of All Funds
2.04%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.02%
New
52
Increased
17
Reduced
10
Closed
8
Calls
$2.36M
Puts
$1.47M
Net Calls
+$895K
Net Calls Change
+$915K
Name Holding Trade Value Shares
Change
Change in
Stake
D.E. Shaw & Co
26
D.E. Shaw & Co
New York
$1.27M +$1.25M +33 New
MIM
27
Monashee Investment Management
Massachusetts
$1.16M -$152K -4 Closed
BCM
28
Bridgeway Capital Management
Texas
$1.16M
PVI
29
Pura Vida Investments
New York
$1.16M +$1.14M +30 New
EGI
30
EAM Global Investors
California
$1.15M +$1.14M +30 New
OA
31
Omega Advisors
New York
$1.1M +$1.06M +28 New
CAM
32
ClariVest Asset Management
California
$1.01M +$987K +26 New
FAM
33
Fred Alger Management
New York
$813K +$797K +21 New
BBA
34
Baker Bros. Advisors
New York
$774K
TCIM
35
TIAA CREF Investment Management
New York
$737K +$721K +19 New
LCS
36
Levin Capital Strategies
New York
$698K +$683K +18 New
Susquehanna International Group
37
Susquehanna International Group
Pennsylvania
$584K -$911K -24 -62%
PCM
38
Perkins Capital Management
Minnesota
$581K +$569K +15 New
SIA
39
Sit Investment Associates
Minnesota
$575K +$569K +15 New
Bank of New York Mellon
40
Bank of New York Mellon
New York
$556K +$342K +9 +180%
UBS Group
41
UBS Group
Switzerland
$509K +$190K +5 +63%
Charles Schwab
42
Charles Schwab
California
$444K +$417K +11 New
BFM
43
Boothbay Fund Management
New York
$426K +$417K +11 New
DCM
44
Driehaus Capital Management
Illinois
$426K +$417K +11 New
Simplex Trading
45
Simplex Trading
Illinois
$405K +$380K +10 New
OAM
46
Oxford Asset Management
United Kingdom
$384K +$380K +10 New
Two Sigma Advisers
47
Two Sigma Advisers
New York
$321K +$304K +8 New
AQR Capital Management
48
AQR Capital Management
Connecticut
$310K +$304K +8 New
California State Teachers Retirement System (CalSTRS)
49
California State Teachers Retirement System (CalSTRS)
California
$303K +$304K +8 New
KeyBank National Association
50
KeyBank National Association
Ohio
$271K +$38K +1 +17%

TTOO Hedge Fund Activity: Q2 2018 in Review

89 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in T2 Biosystems, Inc (TTOO) for Q2 2018, worth a combined $203M — up 65% from $123M a quarter earlier.

Buyers outnumbered sellers: 52 funds opened new TTOO positions and 8 closed out — a net gain of 44 holders — while 17 added to existing stakes and 10 trimmed.

The largest buyer was BlackRock, adding an estimated $12.6M. The largest seller was Tiger Management, cutting an estimated $7.7M.

  • 89 institutional investors held T2 Biosystems, Inc (TTOO) as of Q2 2018, up from 45 in Q1 2018.
  • Funds reported $203M of T2 Biosystems, Inc stock for Q2 2018, up 65% quarter-over-quarter.
  • 52 funds opened new T2 Biosystems, Inc positions in Q2 2018 and 8 closed out, a net change of +44 holders.
  • The largest T2 Biosystems, Inc buyer in Q2 2018 was BlackRock, an estimated $12.6M added.
  • The largest T2 Biosystems, Inc seller in Q2 2018 was Tiger Management, an estimated $7.7M sold.

Based on aggregated 13F filings for Q2 2018.